echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Strengthen the protection of intellectual property rights and release the vitality of pharmaceutical innovation

    Strengthen the protection of intellectual property rights and release the vitality of pharmaceutical innovation

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "Innovation is the first driving force for development, and protecting intellectual property rights is protecting innovation.
    " "The new drug patent right period compensation system is conducive to encouraging pharmaceutical innovation and creating a good innovation environment.
    In the end, patients and society can benefit from innovation.
    "On the one hand, pharmaceutical patents must strengthen the protection of innovation, and on the other hand, they must strike a balance with generic drugs.
    "

    "Innovation is the first driving force for development, and protecting intellectual property rights is protecting innovation.
    " "The new drug patent right period compensation system is conducive to encouraging pharmaceutical innovation and creating a good innovation environment.
    In the end, patients and society can benefit from innovation.
    "On the one hand, pharmaceutical patents must strengthen the protection of innovation, and on the other hand, they must strike a balance with generic drugs.
    "

    Recently, on the occasion of the 21st "World Intellectual Property Day", Cheng Yongshun, Director of Beijing Pragmatic Intellectual Property Development Center, Ji Liwen, President and General Manager of Eli Lilly China, Chief Intellectual Property Consultant and Assistant Vice President of AstraZeneca China and Asia Dr.
    Xu Feng served as a guest on People's Health.
    com, and discussed the new patent law and intellectual property related topics to be implemented.

    Recently, on the occasion of the 21st "World Intellectual Property Day", Cheng Yongshun, Director of Beijing Pragmatic Intellectual Property Development Center, Ji Liwen, President and General Manager of Eli Lilly China, Chief Intellectual Property Consultant and Assistant Vice President of AstraZeneca China and Asia Dr.
    Xu Feng served as a guest on People's Health.
    com, and discussed the new patent law and intellectual property related topics to be implemented.

    The implementation of the new patent law is imminent, and pharmaceutical innovation releases new vitality

    The implementation of the new patent law is imminent, and pharmaceutical innovation releases new vitality

    The fourth revision of the "Patent Law" will come into effect on June 1 this year.
    The new patent law adds a new drug patent linkage system, and for the first time proposed a new drug patent term compensation system at the legislative level.
    Cheng Yongshun pointed out that the development of my country's pharmaceutical industry is in the transition period from generic drugs to innovative drugs.
    The implementation of the new patent law can not only stimulate the improvement of local innovation capabilities, and break through the "stuck neck" problems in drugs, vaccines, and medical devices.
    Promoting the development of innovative drugs in our country can also better benefit the majority of patients and promote the early realization of national health.

    The fourth revision of the "Patent Law" will come into effect on June 1 this year.
    The new patent law adds a new drug patent linkage system, and for the first time proposed a new drug patent term compensation system at the legislative level.
    Cheng Yongshun pointed out that the development of my country's pharmaceutical industry is in the transition period from generic drugs to innovative drugs.
    The implementation of the new patent law can not only stimulate the improvement of local innovation capabilities, and break through the "stuck neck" problems in drugs, vaccines, and medical devices.
    Promoting the development of innovative drugs in our country can also better benefit the majority of patients and promote the early realization of national health.

    Xu Feng believes that the implementation of the new patent law will play a positive role in promoting my country's original research drugs, generic drugs and even the overall pharmaceutical innovation and development.
    "It is foreseeable that my country's investment in new drug research and development will increase significantly in the future.
    At the same time, on the basis of encouraging innovation, balancing the generic drug system will help promote the positive development of the overall medical landscape, and will also promote Chinese companies to expand internationally.
    Vision and global market.
    "

    Xu Feng believes that the implementation of the new patent law will play a positive role in promoting my country's original research drugs, generic drugs and even the overall pharmaceutical innovation and development.
    "It is foreseeable that my country's investment in new drug research and development will increase significantly in the future.
    At the same time, on the basis of encouraging innovation, balancing the generic drug system will help promote the positive development of the overall medical landscape, and will also promote Chinese companies to expand internationally.
    Vision and global market.
    "

    Ji Liwen also affirmed the positive impact of the new patent law.
    He said that in recent years, Chinese local pharmaceutical companies have continued to make efforts in innovation, among which Eli Lilly has also participated in a number of innovation cooperation.
    The implementation of the new patent law will bring major benefits to both foreign-funded pharmaceutical companies in China and local innovative pharmaceutical companies.

    Ji Liwen also affirmed the positive impact of the new patent law.
    He said that in recent years, Chinese local pharmaceutical companies have continued to make efforts in innovation, among which Eli Lilly has also participated in a number of innovation cooperation.
    The implementation of the new patent law will bring major benefits to both foreign-funded pharmaceutical companies in China and local innovative pharmaceutical companies.

    In addition, Xu Feng believes that with reference to international practices and domestic past practices, in the implementation rules of the new Patent Law, the actual situation of innovative pharmaceutical companies should be considered, and the patent protection period compensation transition clause should be established to allow some early response to policy requirements and earlier Innovative pharmaceutical companies that have completed the research and development of innovative drugs and applied for marketing approval can also benefit from the new law.

    In addition, Xu Feng believes that with reference to international practices and domestic past practices, in the implementation rules of the new Patent Law, the actual situation of innovative pharmaceutical companies should be considered, and the patent protection period compensation transition clause should be established to allow some early response to policy requirements and earlier Innovative pharmaceutical companies that have completed the research and development of innovative drugs and applied for marketing approval can also benefit from the new law.

     

    Implement the drug patent linkage system and promote the balance of innovation and imitation

    Implement the drug patent linkage system and promote the balance of innovation and imitation

    Regarding the implementation of the drug patent linkage system, Ji Liwen said that the system has strengthened the protection of drug patents, on the one hand, it has increased the innovation enthusiasm of enterprises, and on the other hand, it can also resolve patent ownership disputes and reduce litigation before the end of drug approval.
    risk.

    Regarding the implementation of the drug patent linkage system, Ji Liwen said that the system has strengthened the protection of drug patents, on the one hand, it has increased the innovation enthusiasm of enterprises, and on the other hand, it can also resolve patent ownership disputes and reduce litigation before the end of drug approval.
    risk.

    "Eli Lilly has a very strong product pipeline.
    In the past three years, an average of 4 new products/new indications were launched each year.
    In the next five years, it is expected to promote 40 innovations into the Chinese market.
    In the future, Lilly is also very much looking forward to the new patent law.
    During the implementation process, actively cooperate with the government and the industry.
    " Ji Liwen said.

    "Eli Lilly has a very strong product pipeline.
    In the past three years, an average of 4 new products/new indications were launched each year.
    In the next five years, it is expected to promote 40 innovations into the Chinese market.
    In the future, Lilly is also very much looking forward to the new patent law.
    During the implementation process, actively cooperate with the government and the industry.
    " Ji Liwen said.

    Cheng Yongshun suggested that on the one hand, pharmaceutical patents should be strengthened to protect innovation, and on the other hand, they should strike a balance with generic drugs.
    Through the legitimate market competition of innovative drugs and generic drugs, people can get good and cheap drugs, overcome diseases, and ultimately benefit the people.

    Cheng Yongshun suggested that on the one hand, pharmaceutical patents should be strengthened to protect innovation, and on the other hand, they should strike a balance with generic drugs.
    Through the legitimate market competition of innovative drugs and generic drugs, people can get good and cheap drugs, overcome diseases, and ultimately benefit the people.

    The 14th Five-Year Plan for the National Economic and Social Development of the People's Republic of China and the Outline of Long-Term Goals for 2035 proposes to implement the strategy of strengthening the country with intellectual property rights, optimize patent subsidy and reward policies and evaluation and evaluation mechanisms, and better protect and encourage high-value patents.
    Cultivate patent-intensive industries.
    Xu Feng believes that the implementation of the new patent law will also further promote the effective transformation and application of some scientific research projects after applying for patent authorization.
    Promote all-round and multi-level cooperation in the industry, and promote the marketization and commercialization of some intellectual property rights.

    The 14th Five-Year Plan for the National Economic and Social Development of the People's Republic of China and the Outline of Long-Term Goals for 2035 proposes to implement the strategy of strengthening the country with intellectual property rights, optimize patent subsidy and reward policies and evaluation and evaluation mechanisms, and better protect and encourage high-value patents.
    Cultivate patent-intensive industries.
    Xu Feng believes that the implementation of the new patent law will also further promote the effective transformation and application of some scientific research projects after applying for patent authorization.
    Promote all-round and multi-level cooperation in the industry, and promote the marketization and commercialization of some intellectual property rights.

     

    Weave a dense protection network to improve my country's intellectual property environment

    Weave a dense protection network to improve my country's intellectual property environment

    In strengthening the protection of the legitimate rights and interests of patentees, the newly revised Patent Law has increased the compensation for patent infringement.
    The statutory compensation amount has been increased from "10,000 yuan to 1 million yuan" to "30,000 yuan to 5 million yuan.
    " Cheng Yongshun pointed out that this move reflects my country's determination and strength in encouraging and protecting innovation, and will help stimulate the innovation vitality of the entire society and promote the construction of a new development pattern.

    In strengthening the protection of the legitimate rights and interests of patentees, the newly revised Patent Law has increased the compensation for patent infringement.
    The statutory compensation amount has been increased from "10,000 yuan to 1 million yuan" to "30,000 yuan to 5 million yuan.
    " Cheng Yongshun pointed out that this move reflects my country's determination and strength in encouraging and protecting innovation, and will help stimulate the innovation vitality of the entire society and promote the construction of a new development pattern.

    "For the relevant provisions of compensation, the important thing is not the specific amount, but the release of clearer and more standard information on the enforcement of infringement.
    I hope that possible infringements can be resolved at an earlier link and promote the standardized and innovative development of the industry.
    "Ji Liwen said.

    "For the relevant provisions of compensation, the important thing is not the specific amount, but the release of clearer and more standard information on the enforcement of infringement.
    I hope that possible infringements can be resolved at an earlier link and promote the standardized and innovative development of the industry.
    "Ji Liwen said.

    Xu Feng believes that, generally speaking, the increased penalties will promote the overall improvement of my country's intellectual property environment.
    For the medical field, it will also promote the further exploration of my country's medicine in the "combination of innovation and imitation" and "from imitation to innovation".

    Xu Feng believes that, generally speaking, the increased penalties will promote the overall improvement of my country's intellectual property environment.
    For the medical field, it will also promote the further exploration of my country's medicine in the "combination of innovation and imitation" and "from imitation to innovation".

    This revision of the Patent Law has two characteristics, one is to encourage innovation, and the other is to encourage popularization and application.
    For the medical field, encouraging innovation corresponds to the research and development of new drugs, and the promotion and application of corresponding generic drugs are complementary and indispensable.
    The three guests once again looked forward to the implementation of the new patent law.
    (This article is transferred from People's Daily Online)
     

    This revision of the Patent Law has two characteristics, one is to encourage innovation, and the other is to encourage popularization and application.


    For the medical field, encouraging innovation corresponds to the research and development of new drugs, and the promotion and application of corresponding generic drugs are complementary and indispensable.
    The three guests once again looked forward to the implementation of the new patent law.
    (This article is transferred from the People's Daily Online)
    html">How does Yifang Jianshu's "Daoshu Use" promote the digital transformation of medical care to the fast lane?
    html">Chinese brand, shared by the world! Lianhua Qingwen brings the Lianhua series of disinfection products to the 2021 China Brand Day
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.